T1	Procedure 59 61	MS
T2	Procedure 272 282	injectable
T3	Procedure 283 285	MS
T4	Procedure 286 293	therapy
T5	Procedure 461 463	mg
T6	Procedure 693 740	cardiac echocardiography as standard monitoring
T7	Procedure 701 717	echocardiography
T8	Procedure 771 780	treatment
T9	Procedure 791 805	echocardiogram
T10	Procedure 918 944	intravenous pulse steroids
T11	Procedure 984 987	MRI
T12	Procedure 1027 1030	MRI
T13	Procedure 1185 1192	therapy
T14	Procedure 1198 1200	mg
T15	Procedure 1215 1218	ECG
T16	Procedure 1297 1299	mg
T17	Procedure 1576 1579	ECG
T18	Procedure 1648 1662	ECG monitoring
T19	Procedure 1648 1651	ECG
T20	Procedure 1962 1965	ECG
T21	Procedure 2048 2057	treatment
T22	Procedure 2258 2265	primary
T23	Procedure 2408 2411	ECG
T24	Procedure 2488 2491	ECG
T25	Procedure 2664 2667	ECG
T26	Procedure 2856 2870	echocardiogram
T27	Procedure 3013 3016	ECG
T28	Procedure 3103 3114	cardiac MRI
T29	Procedure 3111 3114	MRI
T30	Procedure 3234 3245	enhancement
T31	Procedure 38 87	-year-old woman with MS since the age of 23 years
T32	Procedure 264 314	refused injectable MS therapy due to needle phobia
T33	Procedure 443 467	total dose 108.72 mg/m 2
T34	Procedure 693 780	cardiac echocardiography as standard monitoring during and after mitoxantrone treatment
T35	Procedure 782 805	The last echocardiogram
T36	Procedure 969 987	A repeat brain MRI
T37	Procedure 1023 1030	the MRI
T38	Procedure 1174 1192	fingolimod therapy
T39	Procedure 1194 1206	0.5 mg/daily
T40	Procedure 1207 1218	. Basal ECG
T41	Procedure 1283 1303	prednisone 30 mg/day
T42	Procedure 1542 1579	Ventricular tachycardia on Holter-ECG
T43	Procedure 1637 1662	the Holter-ECG monitoring
T44	Procedure 1962 1978	ECG at discharge
T45	Procedure 2027 2070	the first 15 days of treatment, the patient
T46	Procedure 2254 2280	her primary care physician
T47	Procedure 2404 2411	the ECG
T48	Procedure 2464 2496	the results of a Holter-ECG that
T49	Procedure 2630 2667	The mean heart rate during Holter-ECG
T50	Procedure 2842 2870	A new cardiac echocardiogram
T51	Procedure 3004 3016	A Holter-ECG
T52	Procedure 3103 3114	cardiac MRI
T53	Procedure 3199 3245	no intramyocardial late gadolinium enhancement
T54	Disease_disorder 59 61	MS
T55	Disease_disorder 108 123	cardiac disease
T56	Disease_disorder 116 123	disease
T57	Disease_disorder 164 179	cardiac disease
T58	Disease_disorder 172 179	disease
T59	Disease_disorder 283 285	MS
T60	Disease_disorder 301 314	needle phobia
T61	Disease_disorder 308 314	phobia
T62	Disease_disorder 392 399	relapse
T63	Disease_disorder 896 903	relapse
T64	Disease_disorder 1424 1435	bradycardia
T65	Disease_disorder 1542 1565	Ventricular tachycardia
T66	Disease_disorder 1588 1591	all
T67	Disease_disorder 1694 1717	ventricular tachycardia
T68	Disease_disorder 1855 1878	ventricular tachycardia
T69	Disease_disorder 1996 2001	sinus
T70	Disease_disorder 2698 2720	atrioventricular block
T71	Disease_disorder 2715 2720	block
T72	Disease_disorder 2896 2930	mitral and tricuspid insufficiency
T73	Disease_disorder 2907 2930	tricuspid insufficiency
T74	Disease_disorder 2935 2957	atrial septal aneurysm
T75	Disease_disorder 2949 2957	aneurysm
T76	Disease_disorder 3055 3060	sinus
T77	Disease_disorder 3088 3098	arrhythmia
T78	Disease_disorder 38 87	-year-old woman with MS since the age of 23 years
T79	Disease_disorder 94 123	no history of cardiac disease
T80	Disease_disorder 157 179	family cardiac disease
T81	Disease_disorder 264 314	refused injectable MS therapy due to needle phobia
T82	Disease_disorder 388 399	any relapse
T83	Disease_disorder 882 903	a spinal cord relapse
T84	Disease_disorder 1398 1445	A single brief episode of bradycardia at 48 bpm
T85	Disease_disorder 1542 1579	Ventricular tachycardia on Holter-ECG
T86	Disease_disorder 1588 1618	all the most relevant episodes
T87	Disease_disorder 1673 1717	The short episode of ventricular tachycardia
T88	Disease_disorder 1833 1884	the initiation of the ventricular tachycardia there
T89	Disease_disorder 1996 2018	sinus rhythm at 70 bpm
T90	Disease_disorder 2695 2720	No atrioventricular block
T91	Disease_disorder 2891 2930	mild mitral and tricuspid insufficiency
T92	Disease_disorder 2935 2957	atrial septal aneurysm
T93	Disease_disorder 3048 3098	normal sinus rhythm with no episodes of arrhythmia
T94	Sign_symptom 24 35	underweight
T95	Sign_symptom 44 75	old woman with MS since the age
T96	Sign_symptom 97 107	history of
T97	Sign_symptom 97 104	history
T98	Sign_symptom 464 465	m
T99	Sign_symptom 482 483	m
T100	Sign_symptom 644 660	cardiac function
T101	Sign_symptom 1003 1005	T2
T102	Sign_symptom 1088 1094	lesion
T103	Sign_symptom 1554 1565	tachycardia
T104	Sign_symptom 1706 1717	tachycardia
T105	Sign_symptom 1837 1847	initiation
T106	Sign_symptom 1867 1878	tachycardia
T107	Sign_symptom 1902 1923	prolonged QT interval
T108	Sign_symptom 1902 1914	prolonged QT
T109	Sign_symptom 1996 2008	sinus rhythm
T110	Sign_symptom 2111 2118	feeling
T111	Sign_symptom 2203 2212	dizziness
T112	Sign_symptom 2214 2222	asthenia
T113	Sign_symptom 2227 2236	headaches
T114	Sign_symptom 2290 2311	normal blood pressure
T115	Sign_symptom 2290 2296	normal
T116	Sign_symptom 2297 2311	blood pressure
T117	Sign_symptom 2303 2311	pressure
T118	Sign_symptom 2316 2328	heart rhythm
T119	Sign_symptom 2763 2778	discontinuation
T120	Sign_symptom 2794 2802	symptoms
T121	Sign_symptom 2806 2815	dizziness
T122	Sign_symptom 2820 2828	asthenia
T123	Sign_symptom 2880 2886	normal
T124	Sign_symptom 3048 3067	normal sinus rhythm
T125	Sign_symptom 3048 3054	normal
T126	Sign_symptom 3055 3098	sinus rhythm with no episodes of arrhythmia
T127	Sign_symptom 3055 3067	sinus rhythm
T128	Sign_symptom 3122 3128	normal
T129	Sign_symptom 11 53	a case of an underweight 37-year-old woman
T130	Sign_symptom 38 87	-year-old woman with MS since the age of 23 years
T131	Sign_symptom 94 123	no history of cardiac disease
T132	Sign_symptom 443 467	total dose 108.72 mg/m 2
T133	Sign_symptom 470 483	height 1.67 m
T134	Sign_symptom 640 660	Her cardiac function
T135	Sign_symptom 995 1010	six new T2 foci
T136	Sign_symptom 1067 1127	a small non-enhanced lesion in the floor of the IV ventricle
T137	Sign_symptom 1542 1579	Ventricular tachycardia on Holter-ECG
T138	Sign_symptom 1673 1717	The short episode of ventricular tachycardia
T139	Sign_symptom 1833 1884	the initiation of the ventricular tachycardia there
T140	Sign_symptom 1890 1923	no signs of prolonged QT interval
T141	Sign_symptom 1996 2018	sinus rhythm at 70 bpm
T142	Sign_symptom 2110 2125	'feeling great'
T143	Sign_symptom 2177 2212	continuous and unspecific dizziness
T144	Sign_symptom 2214 2236	asthenia and headaches
T145	Sign_symptom 2290 2311	normal blood pressure
T146	Sign_symptom 2752 2778	fingolimod discontinuation
T147	Sign_symptom 2780 2802	the patient's symptoms
T148	Sign_symptom 2791 2828	's symptoms of dizziness and asthenia
T149	Sign_symptom 2878 2889	a normal EF
T150	Sign_symptom 3048 3098	normal sinus rhythm with no episodes of arrhythmia
T151	Sign_symptom 3122 3160	normal biventricular systolic function
T152	Anatomical_structure 108 115	cardiac
T153	Anatomical_structure 125 139	cardiovascular
T154	Anatomical_structure 164 171	cardiac
T155	Anatomical_structure 644 651	cardiac
T156	Anatomical_structure 693 700	cardiac
T157	Anatomical_structure 884 895	spinal cord
T158	Anatomical_structure 957 961	oral
T159	Anatomical_structure 978 983	brain
T160	Anatomical_structure 1118 1127	ventricle
T161	Anatomical_structure 2297 2302	blood
T162	Anatomical_structure 2316 2321	heart
T163	Anatomical_structure 2390 2392	ER
T164	Anatomical_structure 2558 2560	ER
T165	Anatomical_structure 2639 2644	heart
T166	Anatomical_structure 2848 2855	cardiac
T167	Anatomical_structure 2935 2941	atrial
T168	Anatomical_structure 3103 3110	cardiac
T169	Medication 352 364	mitoxantrone
T170	Medication 514 526	mitoxantrone
T171	Medication 758 770	mitoxantrone
T172	Medication 1283 1293	prednisone
T173	Medication 693 780	cardiac echocardiography as standard monitoring during and after mitoxantrone treatment
T174	Medication 1283 1303	prednisone 30 mg/day
